As New Zealand's Omicron infections rise rapidly, genome surveillance is shifting gears

By David Welch, Senior Lecturer, University of Auckland
James Hadfield, Bedford Lab / Nextstrain, Fred Hutchinson Cancer Center
Jemma Geoghegan, Senior Lecturer and Associate Scientist at ESR, University of Otago
Joep de Ligt, Science Lead Genomics & Bioinformatics, ESR
Michael Bunce, Professor, Principal Scientist (Genomics), ESR

Without genome sequencing, we would be blind to new variants of COVID-19. As Omicron surges in New Zealand, the sequencing focus is shifting to learning about what causes severe or long-term disease.

Read complete article

~	What this year’s Tropfest winning film tells us about mothers in the screen industry

~	Paralympic politics: how Russia, Belarus and Israel sparked opening ceremony boycotts

~	The debate NZ should really be having about language policy

~	Are Google’s ‘preferred sources’ a good thing for online news?

~	GLP-1 drugs like Ozempic may lower the risk of addiction: new study

~	The world’s largest climate finance deal was built to flounder: why funding fails to reach the front-line

~	For 27 years, the Kyle and Jackie O Show indulged Australia’s most vulgar, sexist impulses

~	What is wabi-sabi? Will this Japanese philosophy make me happy?

~	How Australia and NZ rules on plant milks differ from overseas, where cows make the only ‘milk’

~	Mark Carney highlights areas of Australian-Canadian cooperation as middle powers